Calcitroic acid
Calcitroic acid is a metabolite of vitamin D that is produced in the kidneys. It is the final product of the vitamin D metabolism pathway and is excreted in the urine. Calcitroic acid is not biologically active, but its production and excretion are important for maintaining the balance of vitamin D in the body.
Metabolism[edit]
Vitamin D is converted into calcitroic acid through a series of enzymatic reactions. First, vitamin D is converted into calcidiol in the liver. This is then converted into calcitriol, the active form of vitamin D, in the kidneys. Finally, calcitriol is converted into calcitroic acid by the enzyme 24-hydroxylase.
Function[edit]
Although calcitroic acid is not biologically active, it plays a crucial role in the regulation of vitamin D metabolism. The production of calcitroic acid from calcitriol is a way for the body to remove excess vitamin D. This is important because too much vitamin D can lead to hypercalcemia, a condition characterized by high levels of calcium in the blood, which can cause various health problems.
Clinical significance[edit]
Abnormal levels of calcitroic acid in the urine can indicate problems with vitamin D metabolism. For example, low levels of calcitroic acid can suggest a deficiency in vitamin D, while high levels can indicate an excess of vitamin D. Measurement of calcitroic acid levels can therefore be used as a diagnostic tool in the evaluation of vitamin D-related disorders.
See also[edit]
References[edit]
This vitamin-related article is a stub. You can help WikiMD by expanding it.
Calcitroic_acid[edit]
-
Calcitroic acid
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian